Dr. John Cush RheumNow
3 years 5 months ago
The Origin Story: Women in Rheumatology--The XX Factor
When asked to run a campaign to highlight the achievements and challenges of women in rheumatology, I was ecstatic because we have has so many heroines who have contributed to our field.
https://t.co/ucQIPjQ8Tu https://t.co/g81EtAwYYL
TheDaoIndex KDAO2011
3 years 5 months ago
"You can have it all...
... but not all at the same time
... or all the time."- @UnaMakris
@rheumnow @uptoTate Watch today's Tuesday Night Rheumatology on https://t.co/kG93OYaNIx
Dr. John Cush RheumNow
3 years 5 months ago
Intrathecal Methotrexate For Cerebritis
Dr. Jack Cush reviews the CV advantage to walking, the OA risk with running and the eczema-OA connection; these articles and journal reports from the past week on RheumNow.
https://t.co/qvOM4p4g7Q https://t.co/QeOPbAapL1
Dr. Megan Clowse from Duke University talks about changing how she talks to patients with lupus, exploring and treating two types of lupus.
Dr. John Cush RheumNow
3 years 5 months ago
There are 27 US States where Nurse Practitioners have "Full Practice Authority" - including WA, OR, NV, ID, UT, MT, AZ, CO, WY, NM, ND, SD, NE, KS, Minn, NY, ME, VT, NH, MA, CT, RI, MD, DE, DC https://t.co/VtqssiGAB0 https://t.co/Zm8Rl7wox8
Dr. John Cush RheumNow
3 years 5 months ago
Drs. Tate and Dao will be leading discussions on Women in Rheumatology, the XX Factor.
Sign up to attend our Tuesday Night Rheumatology series.
@uptoTate @KDAO2011
https://t.co/ciEAY1SJdg https://t.co/dlCfXItAxN
Dr. John Cush RheumNow
3 years 5 months ago
Aug 2022 Ann Int Med reports a Compensation study of 1435 matched male (881) & female (554) PCPs; Shows that despite being a growing share of the workforce, Women PCPs earned median of $58 829 less than male PCPs. https://t.co/iS9oFvdjgq https://t.co/pqm1DEqh7z
When I first took on the role as the American College of Rheumatology (ACR) Committee on Government Affairs chair, I was keenly aware of being the first woman to be nominated to this position. While the demographics of government officials have changed over the past several decades, governance positions are held overwhelmingly by men. Having my voice heard and advocating for my colleagues at the ACR, and most importantly for our patients, were
BRIDGE-PMR proof-of-concept trial assessed the efficacy of rituximab (RTX) in patients with polymyalgia rheumatica (PMR) and showed that a single 1000 mg dose of lead to a significant number of glucocorticoid-free remissions after 1 year.
Dr. John Cush RheumNow
3 years 5 months ago
Gout - Hot Topics in March 2023
A number of new reports this month shed new light on old issues in Gout.
https://t.co/Uuoxf8ghcr https://t.co/5S6m0PWj7h
British Society for Rheumatology (BSR) last published its guideline for systemic sclerosis (SSc) in 2016. Given the many advances in the field the BSR has outlined their plans to update the management of SSc.
Dr. John Cush RheumNow
3 years 5 months ago
Among 182 adult #RA pts - half (50%) had Depression and 25% had anxiety. Patients with depression or anxiety had higher HAQ and DAS28 scores. Depression was more prevalent in females, housewives, & low education. Anxiety more in blue-collar workers https://t.co/C9Foulu29l https://t.co/tcCaV85kU0
Dr. John Cush RheumNow
3 years 5 months ago
Paxlovid (Nirmatrelvir-Ritonavir) should be used w/in 5d of COVID Sxs onset. Drug interactions include: steroids, anticoagulants (Eliquis, Xarelto, warfarin), Flomax, Calcium channel blockers, benzodiazepines. https://t.co/VZpS1z3OGR https://t.co/hR6JAJ3BBO
Dr. John Cush RheumNow
3 years 5 months ago
Atopic Disease Increases Osteoarthritis Risk
Analysis of commercial insurance claims suggests that patients with asthma or atopic dermatitis have a significantly increased risk of osteoarthritis (OA).
https://t.co/450DnhOfY5 https://t.co/zUfD4jhumY
Dr. John Cush RheumNow
3 years 5 months ago
Frunevetmab (Solensia), is a cat-specific mAb against nerve growth factor was FDA approved, for use in CATS, to treat the pain of osteoarthritis. CATS! https://t.co/vY0CCMjZmC https://t.co/UnpDpo5fyB
